Increasing number of surgeries due to high prevalence of chronic diseases is expected to fuel market growth
Increasing number of surgeries due to high prevalence of chronic diseases is expected to be a major factor driving growth of global patient positioning devices market during the forecast period. According to World Health Organization (WHO) report, around 23.6 million new cases of cancer are projected to be reported worldwide by 2030. High prevalence of chronic diseases such as cancer and kidney disorders demand for increasing therapeutic and diagnostic procedures including radiation therapy. For instance, according to National Kidney Foundation data 2015, 10% of the population is affected by chronic kidney disease worldwide.
Technological advancements in the field of patient positioning to accelerate the market growth
Latest surgical procedures such as minimally invasive and robotic surgery face various challenges in positioning the patient safely and providing adequate access to the surgical site. Increasing number of robotic surgeries requiring more specific positioners has spurred the patient positioning devices market growth. For instance, D.A. Surgical TrenGuard is one of the most efficient and effective patient positioning system in the market. Sports medicine utilizes a wide range of patient positioning equipment including distraction devices for arthroscopic procedures and small-incisions. For instance, knee surgery, one of the most frequent sports-related surgery, relies majorly on distraction devices compared to manual manipulation of the limb. Advancements in the medical field provide better and new hospital equipment for complex surgeries. Operating table is one of the most vital factor in the field of surgery. An ergonomic design of the patient positioning equipment is projected to minimize the risk injuries and increase workflow efficiencies along with providing accurate delivery of prescribed radiation doses. However, implementation of US Medical Device Excise Tax (MDET) in the U.S. from 2018 can impede market growth. Importers and manufacturers of taxable medical devices will be subjected to 2.3% tax on the U.S. sales.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients